Marchex stock falls 3.15 percent: second-quarter revenue reaches USD 11.00 million
Published on 10/15/2026 at 21:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRevenue and trading metrics
- Marchex reported USD 11.00 million in second-quarter revenue on August 12, 2026.
- The third-quarter revenue outlook was USD 16.00 million to USD 16.50 million on August 12, 2026.
- Marchex stock costs EUR 1.12 at Lang & Schwarz on October 15, 2026 at 9:07 p.m. CEST, minus 3.15 percent versus the Nasdaq prior close.
- The next earnings report is scheduled for November 11, 2026.
Marchex stock fell 3.15 percent against the Nasdaq prior close while its second-quarter revenue reached USD 11.00 million. The figure was reported for the period ended June 30, 2026, and compared with USD 10.60 million in the first quarter, according to Yahoo Finance on August 12, 2026. The latest euro quote puts the stock at EUR 1.12 after the Xetra session.
Third-quarter outlook expands
The company expects third-quarter 2026 revenue of USD 16.00 million to USD 16.50 million and adjusted EBITDA of USD 2.30 million to USD 2.50 million. The outlook includes a full quarter of Archenia, whose acquisition closed on July 1, 2026, according to Yahoo Finance. That creates a clear comparison with the second quarter, which did not include the acquired business.
Price position after hours
At Marchex's Nasdaq listing, the share price was USD 1.23 at 3:09 p.m. ET on October 15, 2026, against a USD 1.27 prior close. The 52-week range was USD 1.15 to USD 2.00, placing the stock USD 0.08, or 6.96 percent, above its low and USD 0.77, or 38.50 percent, below its high. Trading volume reached 22,530 shares against an average of 35,870.
Marchex's second-quarter net loss was USD 408,000, compared with a USD 1.72 million loss in the first quarter. Operating cash flow was negative USD 649,000 in the second quarter, according to the standardized quarterly figures for the period ended June 30, 2026.
Valuation and next report
Market capitalization stood at USD 54.5 million on October 15, 2026, while the trailing price-to-earnings ratio was minus 10.45. Investing.com lists November 11, 2026 as the next earnings date. Its market page also identifies Nasdaq as the primary exchange and reports a USD 4.00 average analyst target, but the target distance exceeds the range used for the article's valuation comparison.
Comparison with peers
MCHX: minus 3.15 percent, P/E minus 10.45, market capitalization USD 54.5 million
Verint Systems (Nasdaq, USD): plus 1.33 percent, P/E minus 154.56, market capitalization USD 1.2 billion
LivePerson (Nasdaq, USD): unchanged, P/E minus 0.23, market capitalization USD 38.2 million
Trading perspective
The contrast is between a larger revenue outlook and a still-negative earnings profile. The next report will show whether the Archenia contribution can move the combined business toward the stated third-quarter range.
Marchex was trading at EUR 1.12 at Lang & Schwarz on October 15, 2026 at 9:07 p.m. CEST, minus 3.15 percent versus the Nasdaq prior close.
The further course of trading is shown by the continuously updated real-time quote of Marchex stock.
Marchex market data
- Company: Marchex, Inc.
- ISIN: US56624R1086
- Ticker: MCHX
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 15, 2026, 9:07 p.m. CEST): EUR 1.12
- Change versus Nasdaq prior close: minus 3.15 percent
- Market capitalization: USD 54.5 million (as of October 15, 2026)
- 52-week range: USD 1.15-2.00 (as of October 15, 2026)
- Sector / Industry: Consumer Cyclicals / Media and Publishing
- Next earnings date: November 11, 2026
Market context: Market report S&P 500.
